Stickdorn, Judith; Stein, Lara; Arnold-Schild, Danielle et al.
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against TumorsACS NANO. Bd. 16. H. 3. 2022 S. 4426-4443
Rampoldi, Francesca; Donato, Elisa; Ullrich, Leon et al.
T cells license immature B cells to produce a broad range of polyreactive antibodiesCELL REPORTS. Bd. 39. H. 8. 2022
Schwarzenbach, Christian; Tatsch, Larissa; Vilar, Juliana Brandstetter et al.
Targeting c-IAP1, c-IAP2, and Bcl-2 eliminates senescent glioblastoma cells following temozolomide treatmentONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 49-49
Winkler, Rene; Magdefrau, Ann-Sophie; Piskor, Eva-Maria et al.
Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibitionONCOGENE. Bd. 41. H. 40. 2022 S. 4560-4572
Nandi, Tulika; Puonti, Oula; Clarke, William T. et al.
tDCS induced GABA change is associated with the simulated electric field in M1, an effect mediated by grey matter volume in the MRS voxelBRAIN STIMULATION. Bd. 15. H. 5. 2022 S. 1153-1162
Kaina, Bernd; Beltzig, Lea; Strik, Herwig
Temozolomide - Just a Radiosensitizer?FRONTIERS IN ONCOLOGY. Bd. 12. 2022
Hassan, Umair; Pillen, Steven; Zrenner, Christoph et al.
The Brain Electrophysiological recording & STimulation (BEST) toolboxBRAIN STIMULATION. Bd. 15. H. 1. 2022 S. 109-115
Eichler, Madeleine; Distler, Ute; Nasrullah, Usman et al.
The caspase-2 substrate p54nrb exhibits a multifaceted role in tumor cell death susceptibility via gene regulatory functionsCELL DEATH & DISEASE. Bd. 13. H. 4. 2022
Neuhaus, Winfried; Reininger-Gutmann, Birgit; Rinner, Beate et al.
The Current Status and Work of Three Rs Centres and Platforms in Europe*ATLA-ALTERNATIVES TO LABORATORY ANIMALS. Bd. 50. H. 6. 2022 S. 381-413
Scheib, Nils; Tiemann, Jessica; Becker, Christian et al.
The Dendritic Cell Dilemma in the Skin: Between Tolerance and ImmunityFRONTIERS IN IMMUNOLOGY. Bd. 13. 2022